Congressman Ami Bera / X/@RepBera
Congressman Ami Bera on July 9 introduced legislation aimed at accelerating the use of artificial intelligence to advance pediatric cancer research, improve treatment options, and expand access to clinical trials.
The bipartisan Accelerating Innovation (AI) for Kids Act was introduced with Congressional Childhood Cancer Caucus co-chairs Rep. Michael McCaul (R-Texas) and Rep. Mike Kelly (R-Pa.).
Also Read: Chirag Sarao becomes first Sikh American at U.S. Air Force Academy
The bill would promote the use of AI to improve pediatric cancer research, modernize data storage and sharing, enhance clinical trial design, and support more personalized treatments for children with cancer.
Bera said the legislation seeks to harness emerging technologies to improve outcomes for young patients facing cancer.
“Pediatric cancer remains one of the most heartbreaking diagnoses any family can face, and we have a responsibility to use every tool available to improve outcomes for children,” Bera said.
“The bipartisan Accelerating Innovation in Medicine for Kids with Cancer Act would leverage cutting-edge AI and data tools to transform pediatric cancer research, improve clinical trial design and access, and deliver more personalized treatment options for young patients. I am proud to support this effort to accelerate innovation, strengthen the Childhood Kelly Data Initiative, and move us closer to ending cancer as we know it,” he said.
McCaul said advances in artificial intelligence have created new opportunities to improve care for children with cancer and noted that the measure builds on President Donald Trump's executive order on pediatric cancer research.
“Since I founded the Childhood Cancer Caucus 17 years ago, advancements in technology have radically expanded the frontiers of healthcare,” McCaul said. “We owe it to our nation's children to leverage cutting-edge AI to improve their care and treatment options. I'm proud to introduce this bill, which codifies and builds on President Trump's executive order to unlock cures for pediatric cancer patients. By empowering AI to continuously drive research forward, we move one step closer to beating this heartbreaking disease once and for all.”
Kelly said Congress should continue pursuing innovative approaches to improve cancer care and patient outcomes.
“Congress should always consider new, innovative ways not only to treat cancer, but to defeat cancer,” Kelly said. “This legislation would leverage artificial intelligence to strengthen patient care and patient outcomes. I’m proud to sponsor the bipartisan Accelerating Innovation in Medicine for Kids with Cancer Act as we work to ensure pediatric cancer patients and their families have every tool at their disposal to receive the care and cures they deserve.”
According to the bill's sponsors, the legislation would strengthen the Childhood Kelly Data Initiative and accelerate the adoption of AI-powered tools to improve research collaboration, clinical decision-making, and treatment development for pediatric cancers. It is also intended to expand access to better-designed clinical trials and help researchers develop more targeted therapies for children.
Discover more at New India Abroad.
ADVERTISEMENT
ADVERTISEMENT
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login